• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CHARLES & COLVARD PARTNERS WITH ETHARA CAPITAL TO EXPAND LAB-GROWN DIAMOND OFFERINGS

    10/9/25 8:30:00 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary
    Get the next $CTHR alert in real time by email

    RESEARCH TRIANGLE PARK, N.C., Oct. 9, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. (OTC:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab-grown diamonds, today announced plans to expand its lab-grown diamond ("LGD") offerings to consumers as well as wholesale markets with the supply chain support from its strategic investor, Ethara Capital ("Ethara"), whose affiliates pioneered Chemical Vapor Deposition LGD manufacturing, and own and operate over 3,000 diamond-growing machines today.

    (PRNewsfoto/Charles & Colvard, Ltd.)

    In June, Ethara Capital announced a Convertible Secured Note Purchase Agreement with Charles & Colvard, and, in September, it converted the first 10% of its Note to the Company's common equity.

    "As consumer awareness of lab-grown diamonds continues to accelerate, we see a significant opportunity to expand our LGD products to leverage on our online platforms and wholesale distribution channels to meet that growing demand," said Don O'Connell, President and CEO of Charles & Colvard. "We are excited to welcome Ethara and its affiliates as strategic investors and supply chain partners. Our partnership with Ethara Group, one of the largest growers in the LGD industry, brings to us an expanded, vertically integrated, and global supply chain of CVD lab-grown diamonds, and, we believe, will unlock tremendous growth opportunities for us," continued O'Connell.

    This partnership and ensuing product expansion initiative will broaden the Company's Caydia® lab-grown diamond fine jewelry offerings with new bridal and fashion designs on charlesandcolvard.com, and, for the first time, enable approved retailers to purchase lab-grown diamonds through the Company's B2B platform, charlesandcolvarddirect.com.

    Charles & Colvard Direct, the Company's online wholesale portal launched last year, will now allow approved retailers and independent jewelers to browse and purchase certified and non-certified loose lab-grown diamonds in a variety of shapes, carat weights, and grading profiles. The addition marks a natural expansion of the platform's existing offerings, which include the Company's Forever One™ and Forever Bright™ moissanite product brands.

    "Our goal has always been to empower our partners and customers with exceptional, high-quality, and responsibly made gemstones," O'Connell continued. "By expanding our LGD jewelry assortments and offering loose stones through our wholesale platform, we're strengthening our positioning in the lab-grown category and giving our customers direct access to lab-grown gems with the quality and consistency they rely on from Charles & Colvard."

    "Charles & Colvard has consistently led the charge in responsibly made gemstones and fine jewelry for decades," said Ruten Bhanderi, Managing Partner at Ethara Capital. "Our investment and supply chain partnership with the Company demonstrates our excitement and aligns with our commitment to support companies reshaping the diamond industry through continuing innovation and vertical integration. Together with our global diamond growing partners, we look forward to elevating Charles & Colvard to new heights as Made, not Mined™ gemstones usher the world into a new diamond age characterized by affordability, quality, consistency, versatility, and social responsibility.

    About Charles & Colvard, Ltd.

    Charles & Colvard, Ltd. (OTC:CTHR) believes that fine jewelry should be as ethical as it is exquisite. Charles & Colvard is the original creator of lab-grown moissanite (a rare gemstone formed from silicon carbide). The Company brings revolutionary gems and fine jewelry to market by using exclusively Made, not Mined™ above-ground gemstones and a dedication to 100% recycled precious metals. The Company's Forever One™ moissanite and Caydia® lab-grown diamond brands provide exceptional quality, incredible value, and a conscious approach to bridal, high-fashion, and everyday jewelry. Charles & Colvard was founded in 1995 and is based in North Carolina's Research Triangle Park region. For more information, please visit charlesandcolvard.com.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements expressing expectations regarding our future and projections relating to our products, sales, revenues, and earnings are typical of such statements and are made under the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives, representations, and contentions and are not historical facts and typically are identified by use of terms such as "may," "will," "should," "could," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "continue," and similar words, although some forward-looking statements are expressed differently.

    All forward-looking statements are subject to the risks and uncertainties inherent in predicting the future. You should be aware that although the forward-looking statements included herein represent management's current judgment and expectations, our actual results may differ materially from those projected, stated, or implied in these forward-looking statements as a result of many factors including, but not limited to, (1) the execution of our business plans could significantly impact our liquidity and there is substantial doubt about our ability to continue as a going concern; (2) our business and our results of operations could be materially adversely affected as a result of general economic and market conditions; (3) our future financial performance depends upon increased consumer acceptance, growth of sales of our products, and operational execution of our strategic initiatives; (4) we face intense competition in the worldwide gemstone and jewelry industry; (5) we are subject to certain risks due to our international operations, distribution channels and vendors; (6) we are currently dependent on a limited number of distributor and retail partners in our Traditional segment for the sale of our products; (7) seasonality of our business may adversely affect our net sales and operating income; (8) sales of moissanite and lab grown diamond jewelry could be dependent upon the pricing of precious metals, which is beyond our control; (9) our current customers may potentially perceive us as a competitor in the finished jewelry business; (10) if the e-commerce opportunity changes dramatically or if e-commerce technology or providers change their models, our results of operations may be adversely affected; (11) we are subject to arbitration, litigation and demands, which could result in significant liability and costs, and impact our resources and reputation; (12) the financial difficulties or insolvency of one or more of our major customers or their lack of willingness and ability to market our products could adversely affect results; (13) negative or inaccurate information on social media could adversely impact our brand and reputation; (14) environmental, social, and governance matters may impact our business, reputation, financial condition, and results of operations; (15) If we fail to evaluate, implement, and integrate strategic acquisition or disposition opportunities successfully, our business may suffer; (16) as a public reporting company, we are subject to rules and regulations established from time to time by the SEC regarding our internal control over financial reporting. If we fail to establish and maintain effective internal control over financial reporting and disclosure controls and procedures, we may not be able to accurately report our financial results, or report them in a timely manner; (17) our recent delisting from The Nasdaq Stock Market and move to over the counter ("OTC") trading could limit the liquidity and price of our common stock; (18) we could be negatively affected as a result of a proxy contest or other actions of activist shareholders; (19) some anti-takeover provisions of our charter documents may delay or prevent a takeover of our Company; in addition to the other risks and uncertainties described in more detail in our filings with the U.S. Securities and Exchange Commission (the "SEC"), including our Annual Report on Form 10-K for the fiscal year ended June 30, 2024 and subsequent reports filed with the SEC. Forward-looking statements speak only as of the date they are made. We undertake no obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur except as required by the federal securities laws, and you are urged to review and consider disclosures that we make in the reports that we file with the Securities and Exchange Commission, or SEC, that discuss other factors relevant to our business.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/charles--colvard-partners-with-ethara-capital-to-expand-lab-grown-diamond-offerings-302579055.html

    SOURCE Charles & Colvard, Ltd.

    Get the next $CTHR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CTHR

    DatePrice TargetRatingAnalyst
    9/3/2021$3.50 → $3.75Buy
    Roth Capital
    More analyst ratings

    $CTHR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital reiterated coverage on Charles & Colvard with a new price target

    Roth Capital reiterated coverage of Charles & Colvard with a rating of Buy and set a new price target of $3.75 from $3.50 previously

    9/3/21 8:46:46 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CHARLES & COLVARD PARTNERS WITH ETHARA CAPITAL TO EXPAND LAB-GROWN DIAMOND OFFERINGS

    RESEARCH TRIANGLE PARK, N.C., Oct. 9, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. (OTC:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab-grown diamonds, today announced plans to expand its lab-grown diamond ("LGD") offerings to consumers as well as wholesale markets with the supply chain support from its strategic investor, Ethara Capital ("Ethara"), whose affiliates pioneered Chemical Vapor Deposition LGD manufacturing, and own and operate over 3,000 diamond-growing machines today. In June, Ethara Capital announced a Con

    10/9/25 8:30:00 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    Charles & Colvard, Ltd. Announces Delisting from Nasdaq

    RESEARCH TRIANGLE PARK, N.C., April 22, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company"), announced that the Company received a staff determination letter from the Nasdaq Stock Market, LLC ("Nasdaq"), informing the Company that Nasdaq determined to suspend trading and delist the Company's common stock (the "Common Stock") from Nasdaq because the Company is out of compliance with Listing Rule 5250(c)(1) for failure to timely file its Forms 10-Q for the quarters ended September 30 and December 31, 2024, unless the Company appeals this determination. The Company does not intend to request a hearing to appeal this determination. This decision was based on a car

    4/22/25 4:45:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    Charles & Colvard, Ltd. Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q

    RESEARCH TRIANGLE PARK, N.C., March 3, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (NASDAQ:CTHR) today announced that on February 25, 2025, it received an expected notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") stating that the Company continues to not be in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"), as a result of not having timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024. Nasdaq previously accepted the Company's plan to regain compliance with the Listing Rule and granted the Company until April 14, 2025 to file its Annual Report on For

    3/3/25 4:45:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    SEC Filings

    View All

    Charles & Colvard Ltd filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - CHARLES & COLVARD LTD (0001015155) (Filer)

    10/16/25 4:30:36 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    SEC Form NT 10-K filed by Charles & Colvard Ltd

    NT 10-K - CHARLES & COLVARD LTD (0001015155) (Filer)

    9/30/25 5:20:02 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    SEC Form D filed by Charles & Colvard Ltd

    D - CHARLES & COLVARD LTD (0001015155) (Filer)

    9/12/25 4:40:28 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $CTHR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    O'Connell Don bought $5,550 worth of shares (15,000 units at $0.37) (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/7/24 4:15:57 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    Sykes Ollin B bought $7,028 worth of shares (19,000 units at $0.37) (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/5/24 6:21:11 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    O'Connell Don bought $4,806 worth of shares (13,350 units at $0.36), increasing direct ownership by 3% to 464,464 units (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/5/24 9:15:15 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    New insider Ethara Capital Llc claimed ownership of 1,353,180 shares (SEC Form 3)

    3 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    10/9/25 3:30:05 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    O'Connell Don bought $5,550 worth of shares (15,000 units at $0.37) (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/7/24 4:15:57 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    Sykes Ollin B bought $7,028 worth of shares (19,000 units at $0.37) (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/5/24 6:21:11 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Leadership Updates

    Live Leadership Updates

    View All

    Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO

    ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Chief Executive Officer Arjan Haverhals will retire from his role as an officer of the company on December 31, 2024. Upon his retirement, Mr. Haverhals will continue to serve as a director on the Board and will provide consulting services to ensure continuity and support through the leadership transition. Mr. Haverhals' retirement, following a distinguished career of over 30 years in the medical device and pharmaceutical industries, reflects his desire to spend more ti

    11/14/24 4:00:00 PM ET
    $CTHR
    $MLSS
    Consumer Specialties
    Consumer Discretionary
    Industrial Specialties
    Health Care

    Charles & Colvard Joins Russell Microcap® Index

    RESEARCH TRIANGLE PARK, N.C., June 28, 2021 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company specializing in lab created moissanite and lab grown diamonds, announced today the Company's addition to the Russell Microcap® Index, effective after the US market opens on June 28, 2021, as a part of the Russell indexes annual reconstitution. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines

    6/28/21 9:16:00 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Financials

    Live finance-specific insights

    View All

    CHARLES & COLVARD REPORTS THIRD QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS

    Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C., May 2, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, reported financial results for the third quarter ended March 31, 2024 ("Third Quarter Fiscal 2024").  Management Commentary  "We remain committed to growth despite a challenging third quarter. We believe our strategic initiatives, continued investments in innovative technology, and dedica

    5/2/24 4:07:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    CHARLES & COLVARD TO HOST THIRD QUARTER FISCAL YEAR 2024 INVESTOR CONFERENCE CALL ON MAY 2, 2024 AT 4:30 PM ET

    RESEARCH TRIANGLE PARK, N.C., April 23, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, will host an investor conference call and webcast presentation to discuss its financial results for the third quarter ended March 31, 2024 ("Third Quarter Fiscal Year 2024") at 4:30 p.m. ET on Thursday, May 2, 2024. The Company will release its financial results after market close on the same day. Third Quarter Fiscal Year 2024 Conference Call DetailsDate and Time: T

    4/23/24 4:08:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    CHARLES & COLVARD REPORTS SECOND QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS

    Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C., Feb. 13, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, reported financial results for the second quarter ended December 31, 2023 ("Second Quarter Fiscal 2024").  Management Commentary  "We acknowledge the recent industry shift has presented us with numerous challenges and has significantly impacted our earnings. However, we do not believe t

    2/13/24 4:07:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Charles & Colvard Ltd (Amendment)

    SC 13D/A - CHARLES & COLVARD LTD (0001015155) (Subject)

    2/26/24 7:00:57 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    SEC Form SC 13G/A filed by Charles & Colvard Ltd (Amendment)

    SC 13G/A - CHARLES & COLVARD LTD (0001015155) (Subject)

    2/14/24 9:00:30 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    SEC Form SC 13D/A filed by Charles & Colvard Ltd (Amendment)

    SC 13D/A - CHARLES & COLVARD LTD (0001015155) (Subject)

    11/20/23 4:15:12 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary